港股异动 | 信义光能(0968.HK)七连跌 股价年内腰斩 机构纷纷大砍目标价
格隆汇5月7日丨信义光能(0968.HK)跌逾8%,暂录七连跌,报10.16港元,股价创去年9月份以来新低,相较于今年1月初创下的历史高点24.8港元,股价已经累计跌去逾59%,最新总市值895亿港元。花旗发布最新研究报告,将信义光能目标价由15港元降23.3%至11.5港元, 重申“中性”评级。该行下调公司2021-23年净利润预测18%至51%,以反映光伏玻璃售价下降。目前2021年预测市盈率19.4倍及市帐率3.5倍,高于历史平均水平54%及35%。瑞信降信义光能目标价至19港元,维持跑赢大市评级;大和则将其目标价降至11.5港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.